The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In ...

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of ...

According to the latest data from the Centers for Disease Control, the current bird flu outbreak has caused 67 human cases of ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

such as avian influenza A(H5N1). The company plans to design up to four new pandemic influenza vaccines and test them in ...

Moderna Inc (NASDAQ:MRNA) stock is trading higher with a session volume of 8.0 million as per data from Benzinga Pro. On ...

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...